Creative Medical Technology Holdings is Granted Patent on Mesenchymal Stem Cells for Female Infertility Pending Quayle Action
- Monday, April 20, 2020, 7:20
- Environment
- Add a comment
PHOENIX, April 20, 2020 /PRNewswire/ — Creative Medical Technology Holdings Inc. (OTC-CELZ) announced today receipt of a Quayle Action on its patent application #15/652213 entitled Methods for Treatment of Premature Ovarian Failure and Ovarian Aging using Regenerative Cells. The patent…
About the Author
adminasapcorp has written 41555 stories on this site.